Before The Bell
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Chelsea Therapeutics International (CHTP) Leaped On FDA Panel Recommendation

RELATED NEWS
Trade CHTP now with 
1/16/2014 7:11 AM ET

Chelsea Therapeutics International (CHTP: Quote) announced after the bell Tuesday that the FDA's Cardiovascular and Renal Drugs Advisory Committee voted 16-1 to recommend approval of NORTHERA, for the treatment of symptomatic neurogenic orthostatic hypotension.

Chelsea Therapeutics gapped open sharply higher Wednesday, but gave back some of its early gains over the course of the trading session. Shares finished with a gain of 2.11 at $4.41 on the highest volume of the year. The stock closed challenging the highs of the year, trading at a week and a half high.

Click here to receive FREE breaking news email alerts for Chelsea Therapeutics International and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus